Literature DB >> 2744350

Mortality in celiac disease.

R F Logan1, E A Rifkind, I D Turner, A Ferguson.   

Abstract

The mortality experienced by a cohort of 653 patients with celiac disease in Edinburgh and the Lothian region has been analyzed. Mortality overall was 1.9-fold (95% confidence limits, 1.5-2.2) that of the general population (115 deaths observed, 61.8 expected; p less than 0.0001). The increased mortality was greatest within 1 yr of diagnosis of celiac disease and steadily declined over time with the excess mortality being concentrated at ages 45-54 yr in men and 55-64 yr in women. Celiac disease was mentioned on the death certificate in 33 cases but in only 10 was it given as the underlying cause of death. Of 17 deaths from lymphoproliferative diseases (0.55 expected, p less than 0.001), 8 occurred within 2 yr of diagnosis of celiac disease compared with 8 (0.37 expected, p less than 0.001) occurring greater than 5 yr after diagnosis. Esophageal cancer was certified as the cause of four deaths (0.47 expected, p less than 0.01). In men mortality from all other malignant disease was also increased (15 deaths observed; 6.4 expected, p less than 0.01), but most of these deaths occurred within 5 yr of the diagnosis of celiac disease. In contrast, there was no deficit in deaths from ischemic heart disease or stroke and the mortality rate in those diagnosed in childhood as having celiac disease was similar to the general population.

Entities:  

Mesh:

Year:  1989        PMID: 2744350     DOI: 10.1016/0016-5085(89)90060-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  55 in total

1.  European and North American populations should be screened for coeliac disease.

Authors:  A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

2.  A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency.

Authors:  M R Howard; A J Turnbull; P Morley; P Hollier; R Webb; A Clarke
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

Review 3.  Celiac disease. CME update for family physicians.

Authors:  Shane M Devlin; Christopher N Andrews; Paul L Beck
Journal:  Can Fam Physician       Date:  2004-05       Impact factor: 3.275

4.  Population based screening for coeliac disease: patient's choice or doctor's decision.

Authors:  S Ishaq
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

5.  Mortality and causes of death in celiac disease in a Mediterranean area.

Authors:  M Cottone; A Termini; L Oliva; A Magliocco; C Marrone; A Orlando; F Pinzone; R Di Mitri; M Rosselli; A Rizzo; L Pagliaro
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 6.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 7.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 8.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 9.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

10.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.